Rodgers Brothers Inc. Has $2.94 Million Stock Holdings in Kenvue Inc. (NYSE:KVUE)

Rodgers Brothers Inc. lowered its position in shares of Kenvue Inc. (NYSE:KVUE) by 27.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 137,908 shares of the company’s stock after selling 51,582 shares during the quarter. Rodgers Brothers Inc.’s holdings in Kenvue were worth $2,944,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in KVUE. Vanguard Group Inc. lifted its position in shares of Kenvue by 0.8% in the fourth quarter. Vanguard Group Inc. now owns 218,543,705 shares of the company’s stock worth $4,665,908,000 after purchasing an additional 1,636,741 shares in the last quarter. State Street Corp lifted its position in Kenvue by 16.8% during the 3rd quarter. State Street Corp now owns 127,213,940 shares of the company’s stock worth $2,942,458,000 after buying an additional 18,283,473 shares in the last quarter. Geode Capital Management LLC lifted its position in Kenvue by 0.9% during the 3rd quarter. Geode Capital Management LLC now owns 44,677,077 shares of the company’s stock worth $1,029,810,000 after buying an additional 399,846 shares in the last quarter. Harris Associates L P boosted its stake in shares of Kenvue by 7.5% during the 3rd quarter. Harris Associates L P now owns 31,459,511 shares of the company’s stock worth $727,658,000 after buying an additional 2,186,114 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its holdings in shares of Kenvue by 2.3% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 24,972,777 shares of the company’s stock valued at $533,169,000 after acquiring an additional 561,570 shares in the last quarter. 97.64% of the stock is owned by institutional investors.

Analyst Ratings Changes

KVUE has been the topic of several analyst reports. Evercore ISI initiated coverage on Kenvue in a report on Monday, March 24th. They set an “in-line” rating and a $25.00 target price on the stock. UBS Group dropped their price objective on Kenvue from $23.00 to $21.00 and set a “neutral” rating on the stock in a research note on Friday, February 7th. Citigroup decreased their target price on shares of Kenvue from $25.00 to $21.00 and set a “neutral” rating for the company in a research note on Wednesday, January 15th. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $24.00 price target on shares of Kenvue in a research report on Monday, February 3rd. Finally, Deutsche Bank Aktiengesellschaft downgraded shares of Kenvue from a “buy” rating to a “hold” rating and decreased their price objective for the company from $25.00 to $24.00 in a research report on Thursday, December 12th. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, Kenvue currently has a consensus rating of “Hold” and a consensus target price of $24.00.

Kenvue Price Performance

Kenvue stock opened at $23.74 on Monday. The company has a market capitalization of $45.36 billion, a price-to-earnings ratio of 44.78, a PEG ratio of 2.62 and a beta of 1.25. The stock’s 50 day moving average is $22.32 and its 200-day moving average is $22.45. The company has a current ratio of 1.00, a quick ratio of 0.69 and a debt-to-equity ratio of 0.66. Kenvue Inc. has a 12 month low of $17.67 and a 12 month high of $24.46.

Kenvue (NYSE:KVUE) last issued its quarterly earnings data on Thursday, February 6th. The company reported $0.26 EPS for the quarter, meeting analysts’ consensus estimates of $0.26. Kenvue had a return on equity of 20.97% and a net margin of 6.66%. Equities research analysts expect that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, February 26th. Shareholders of record on Wednesday, February 12th were issued a $0.205 dividend. This represents a $0.82 dividend on an annualized basis and a yield of 3.45%. The ex-dividend date of this dividend was Wednesday, February 12th. Kenvue’s dividend payout ratio is currently 154.72%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.